Arm Stock Has 20% Downside, According to 1 Wall Street Analyst
Published
Investors bid up Arm after earnings, but that was exactly the wrong decision.
Full ArticlePublished
Investors bid up Arm after earnings, but that was exactly the wrong decision.
Full ArticleGinkgo Bioworks has become a penny stock -- and that's the least of its problems,